Warren R, Blauvelt A, Bagel J, Papp K, Yamauchi P, Armstrong A, Langley R, Vanvoorden V, De Cuyper D, Peterson L, Cross N, Reich K. Bimekizumab Efficacy and Safety versus Adalimumab in Patients with Moderate to Severe Plaque Psoriasis: Results from a Multicenter, Randomized, Double-Blinded Active Comparator-Controlled Phase 3 Trial (BE SURE). J of Skin [Internet]. 2021 Jan. 1 [cited 2024 Jul. 4];5(1):s15. Available from: https://jofskin.org/33014/index.php/skin/article/view/1168